IP Library Granted Patent US 12,472,214
Granted Patent B2
US 12,472,214 · App. 17/798,882 · Granted Nov 18, 2025

Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin D deficiency, and disorders associated therewith

Inventors: Andrea Biffi (Trezzano Rosa, IT); Walter Fiore (Trezzano Rosa, IT)
Assignee: ALFASIGMA S.P.A
A61K35/747A61K31/593A61P3/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,472,214
App. No.
17/798,882
Granted
Nov 18, 2025
Kind
B2
Abstract

The present invention relates to bacterial strains for use in the treatment of vitamin D deficiency and/or insufficiency and/or diseases, symptoms and/or disorders associated thereto. Furthermore, the present invention relates to compositions comprising at least one of said bacterial strains and at least one vitamin D, preferably vitamin D3, and to the use thereof in the treatment of said vitamin D deficiency and/or insufficiency and/or diseases, symptoms or disorders associated thereto.

Claims (9)

1 . A method of treating a patient having a vitamin D deficiency and/or insufficiency (or hypovitaminosis D) and/or of a disease, symptom and/or disorder associated with said vitamin D deficiency, comprising administering to the patient a bacterial strain belongs to the species Lactobacillus paracasei , reclassified Lacticaseibacillus paracasei , wherein said bacterial strain belongs to the species Lactobacillus paracasei is selected from the group consisting of:

a bacterial strain belonging to the species Lactobacillus paracasei identified as Lactobacillus paracasei DG® and deposited at the National Collection of Cultures of Microorganisms of the Pasteur Institute in Paris under the accession number CNCM 1-1572 and name Lactobacillus casei DG® sub. casei , and

a bacterial strain belonging to the species Lactobacillus paracasei identified as Lactobacillus paracasei LPC-SOl® and deposited at Deutsche Sammlung van Mikroorganismen und Zellkulturen GmbH (DSMZ) under the accession number DSM 26760,

and a mixture thereof thereby increasing vitamin D levels in the subject.

2 . The method of claim 1 , wherein said vitamin D deficiency is a vitamin D3 (cholecalciferol) and/or vitamin D2 (ergocalciferol) deficiency and/or insufficiency.

3 . The method of claim 1 , wherein said bacterial strain is administered associated/combined with vitamin D, wherein said administration of said bacterial strain and of vitamin D is simultaneous or delayed over time.

4 . The method of claim 1 , wherein said disease, symptom and/or disorder is selected from: rickets, fragile bones, bone deformation, osteoporosis, osteomalacia, bone pain, joint pain, bone fragility, hypocalcaemia, hypophosphatemia, bone abnormalities due to demineralisation defects.

5 . The method of claim 2 , wherein said vitamin D deficiency is a vitamin D3 deficiency and/or insufficiency.

6 . The method according to claim 3 , wherein said bacterial strain is administered associated/combined with vitamin D3.

Assignments (2)
PARTIAL DEMERGER Recorded Mar 21, 2025
From: SOFAR S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 070661/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2022
From: BIFFI, ANDREA; FIORE, WALTER
To: SOFAR S.P.A.
Reel/Frame 062017/0576 →
Priority Claims (1)
IT 102020000006448 · Mar 26, 2020 · national
Continuity (1)
Related Publication 20230190833A1 · Jun 22, 2023
References Cited (25)
US 20120114608A1 · Ebel et al. · 2012 [cited by applicant]
US 20170246262A1 · Latefi · 2017 [cited by applicant]
EP 2385837A2 · 2011 [cited by applicant]
EP 2455093A1 · 2012 [cited by applicant]
EP 3194567A1 · 2017 [cited by applicant]
KR 20120064416A · 2012 [cited by applicant]
WO WO0172322A2 · 2001 [cited by applicant]
WO WO2006047744A2 · 2006 [cited by applicant]
WO WO2010081126A2 · 2010 [cited by applicant]
WO WO2016030504A1 · 2016 [cited by applicant]
WO WO2019089878A1 · 2019 [cited by applicant]
WO WO2019243168A1 · 2019 [cited by applicant]
Lei M, Guo C, Wang Y, Hua L, Xue S, Yu D, Zhang C, Wang D., Asia Pac J Clin Nutr. 2018;27(6):1252-1257. doi: 10.6133/apjen.201811_27(6).0012 (Year: 2018). [cited by examiner]
Arioli et al., Front. Microbiol., 2018, Sec. Food Microbiology, vol. 9, Article 1720, doi.org/10.3389/fmicb.2018.01720. (Year: 2018). [cited by examiner]
Laird etal., Nutrients 2010, 2, 693-724; doi: 10.3390/nu2070693. (Year: 2010). [cited by examiner]
Balzaretti, “Exploring Lactobacillus paracasei probiosis and metabolic potential”, Internet Citation, 2015, pp. 1-132, retrieved from the Internet: URL:https://air.unimi.it/retrieve/handle/2434/336570/476477/phd_unimi_R… [cited by applicant]
Strate et al., “Antiviral activities of lactoferrin” Antiviral Research, 2001, 52: 225-239. [cited by applicant]
Valenti et al., “Lactoferrin: an important host defence against microbial and viral attack”, Cellular and Molecular Life Sciences, 2005, 62: 2576-2587. [cited by applicant]
Jones et al., “Oral Supplementation With Probiotic L. reuteri NCIMB 30242 Increases Mean Circulating 25-Hydroxyvitamin D: A Post Hoc Analysis of a Randomized Controlled Trial”, Journal of Clinical Endorcrinology Metabol… [cited by applicant]
Shang et al., “Vitamin D/VDR, probiotics, and gastrointestinal diseases”, Current Medicinal Chemistry, 2017, 24(9): 876-887. [cited by applicant]
Gokhale et al., “Provitamin D3 modulation through prebiotics supplementation: simulation based assessment”, Scientific Reports, 2019, 9: 19267. [cited by applicant]
Caccamo et al., “Health Risks of Hypovitaminosis D: A Review of New Molecular Insights”, International Journal of Molecular Sciences, 2018, 19, 892, 18 pages. [cited by applicant]
Ostadmohammadi et al., “Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome”, Journal of Ovarian Research, 201… [cited by applicant]
Yoon et al., “Probiotic Regulation of Vitamin D Receptor in Intestinal Inflammation”, Gastroenterology, 2011, 140(5): S-19. [cited by applicant]
Radicioni et al., “Survival of L. casei DG (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population”, European Journal of Nutrition, 2019, 58: 3161-3170. [cited by applicant]